Familial deletion within NLGN4 associated with autism and Tourette syndrome

Ichtchenko K, Hata Y, Nguyen T et al: Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell 1995; 81: 435–443.

Lise MF, El-Husseini A : The neuroligin and neurexin families: from structure to function at the synapse. Cell Mol Life Sci 2006; 63: 1833–1849.

Boucard AA, Chubykin AA, Comoletti D, Taylor P, Sudhof TC : A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 2005; 48: 229–236.

Levinson JN, Chery N, Huang K et al: Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1beta in neuroligin-induced synaptic specificity. J Biol Chem 2005; 280: 17312–17319.

Varoqueaux F, Aramuni G, Rawson RL et al: Neuroligins determine synapse maturation and function. Neuron 2006; 51: 741–754.

Ullrich B, Ushkaryov YA, Sudhof TC : Cartography of neurexins: more than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons. Neuron 1995; 14: 497–507.

Ichtchenko K, Nguyen T, Sudhof TC : Structures, alternative splicing, and neurexin binding of multiple neuroligins. J Biol Chem 1996; 271: 2676–2682.

Bolliger MF, Frei K, Winterhalter KH, Gloor SM : Identification of a novel neuroligin in humans which binds to PSD-95 and has a widespread expression. Biochem J 2001; 356: 581–588.

Jamain S, Quach H, Betancur C et al: Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27–29.

Laumonnier F, Bonnet-Brilhault F, Gomot M et al: X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004; 74: 552–557.

Yan J, Oliveira G, Coutinho A et al: Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry 2005; 10: 329–332.

Talebizadeh Z, Lam DY, Theodoro MF, Bittel DC, Lushington GH, Butler MG : Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 2006; 43: e21.

Feng J, Schroer R, Yan J et al: High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 2006; 409: 10–13.

Talebizadeh Z, Bittel DC, Veatch OJ, Butler MG, Takahashi TN, Miles JH : Do known mutations in neuroligin genes (NLGN3 and NLGN4) cause autism? J Autism Dev Disord 2004; 34: 735–736.

Gauthier J, Bonnel A, St-Onge J et al: NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet B Neuropsychiatr Genet 2005; 132: 74–75.

Ylisaukko-oja T, Rehnstrom K, Auranen M et al: Analysis of four neuroligin genes as candidates for autism. Eur J Hum Genet 2005; 13: 1285–1292.

Blasi F, Bacchelli E, Pesaresi G, Carone S, Bailey AJ, Maestrini E : Absence of coding mutations in the X-linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 220–221.

Sand P, Langguth B, Hajak G et al: Screening for Neuroligin 4 (NLGN4) truncating and transmembrane domain mutations in schizophrenia. Schizophr Res 2006; 82: 277–278.